Weight changes in children receiving intrathecal baclofen for the treatment of spasticity.
To identify changes in weight for children receiving intrathecal baclofen (ITB) therapy for the treatment of spasticity. Retrospective medical chart review. Weights were obtained before and after ITB pump implantation. Tertiary care children's hospital. 52 children < 20 years old at the time of data collection receiving ITB therapy for the treatment of cerebral origin spasticity for > 1 year. Paired t-test compared pre and post-implantation weights. Analyses of covariance were run to compare differences in overall weight change as defined by variables of gender, diet, diagnosis, and ethnicity. A significant change in pre-implantation weight (M=26.77, SD=11.29) from post-implantation weight (M=32.11, SD=12.62) was noted. No significant weight change was noted among variables. Study participants gained an average of 5.43 kg (SD=4.34) after receiving 1 year of ITB therapy.